Presseportal.ch - Ergebnis der Suchanfrage nach Bristol-Myers Squibb

Integrated voice collaboration, best-in-class compliant communication and the power of connectivity showcased at Symphony’s Innovate New York 2022

info@newsaktuell.ch (presseportal.ch) — Thu, 27 Oct 2022 17:39:28 +0200

News Direct [Newsroom]

New York (ots) - --News Direct-- - The Symphony platform has seen a 500%+ increase in traffic across its compliance-enabled messaging offering for WhatsApp, WeChat and SMS - T. Rowe Price announced 200,000 new connections with JP Morgan counterparts ... Lesen Sie hier weiter...

SOPHiA GENETICS and the Spanish Lung Cancer Group Team Up to Explore the Predictive Potential of Multimodal Health Data in Resectable Stage IIIA Non-Small Cell Lung Cancer

info@newsaktuell.ch (presseportal.ch) — Mon, 08 Feb 2021 10:01:04 +0100

Sophia Genetics [Newsroom]
Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, a global leader in Data-Driven Medicine, announced today a clinical research partnership initiative with the Spanish Lung Cancer Group to apply its radiomics and multimodal ... Lesen Sie hier weiter...

Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics

info@newsaktuell.ch (presseportal.ch) — Mon, 09 Nov 2020 14:07:57 +0100

Merck Healthcare Germany [Newsroom]
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as ... Lesen Sie hier weiter...

DGAP-Adhoc: BB BIOTECH AG: Product approvals and solid company results lead the biotech sector higher

info@newsaktuell.ch (presseportal.ch) — Fri, 20 Oct 2017 07:19:16 +0200

BB Biotech AG [Newsroom]
DGAP-Ad-hoc: BB BIOTECH AG / Key word(s): 9-month figures BB BIOTECH AG: Product approvals and solid company results lead the biotech sector higher 20-Oct-2017 / 07:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted ... Lesen Sie hier weiter...

GSK's Global HIV Business ViiV Healthcare Completes Transactions to Acquire Bristol-Myers Squibb's R&D HIV Assets

info@newsaktuell.ch (presseportal.ch) — Mon, 22 Feb 2016 17:10:28 +0100

GlaxoSmithKline Plc (GSK) [Newsroom]
London (ots/PRNewswire) - GlaxoSmithKline plc (LSE: GSK) today announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, has completed two previously announced ... Lesen Sie hier weiter...

European Liver Patients Association (ELPA) Launches New Digital Guide for People Diagnosed with Hepatitis C

info@newsaktuell.ch (presseportal.ch) — Fri, 24 Apr 2015 09:01:42 +0200

European Liver Patients Association (ELPA) [Newsroom]
Brussels (ots/PRNewswire) - There are approximately nine million people in Europe infected with the hepatitis C virus, with tens of thousands of new cases diagnosed each year - and this trend is rising.[1] Currently there is no single online ... Lesen Sie hier weiter...

CORRECTION - Merck: Merck Strengthens Presence as Leading Oncology Company by Taking Full Promotional Responsibility for Erbitux in Japan

info@newsaktuell.ch (presseportal.ch) — Fri, 13 Feb 2015 09:36:21 +0100

Merck Healthcare Germany [Newsroom]
Darmstadt, Germany (ots/PRNewswire) - In the news release, "Merck Strengthens Presence as Leading Oncology Company by Taking Full Promotional Responsibility for Erbitux in Japan" issued on 13 Feb 2015 06:33 GMT, by Merck over PR Newswire, we are ... Lesen Sie hier weiter...

Merck Strengthens Presence as Leading Oncology Company by Taking Full Promotional Responsibility for Erbitux in Japan

info@newsaktuell.ch (presseportal.ch) — Fri, 13 Feb 2015 07:36:42 +0100

Merck Healthcare Germany [Newsroom]
Darmstadt, Germany (ots/PRNewswire) - - Not intended for US- and UK-based media - Merck and Bristol-Myers Squibb to end co-promotion of Erbitux in Japan, with full promotional responsibilities transferring to Merck Merck, a leading company for ... Lesen Sie hier weiter...

Bristol-Myers Squibb-Sponsored Partnering for Cure(TM) Programme Announces New Winning Projects Designed to Investigate Novel Ways to Cure Viral Diseases

info@newsaktuell.ch (presseportal.ch) — Tue, 11 Nov 2014 13:51:02 +0100

Bristol-Myers Squibb GmbH & Co. KGaA [Newsroom]
Paris (ots/PRNewswire) - The Partnering for Cure faculty of experts today announced the four recipients of awards for research proposals that will help to provide insights into the pathophysiology of viral diseases and the potential development of ... Lesen Sie hier weiter...

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of 'Precision Medicine in Cancer Care'

info@newsaktuell.ch (presseportal.ch) — Fri, 26 Sep 2014 08:31:41 +0200

Merck Healthcare [Newsroom]
Darmstadt, Germany (ots/PRNewswire) - Not intended for US- and UK-based media ESMO 2014 Abstract #: Physician biomarker survey: 1080O_PR; Erbitux: CRYSTAL: 541P; LASCCHN: 993PD; DIRECT: 996P; Pipeline: pimasertib: 443O; c-Met: 1333TiP, 450PD, ... Lesen Sie hier weiter...